306 related articles for article (PubMed ID: 24396276)
1. Tumor Protein p63/microRNA Network in Epithelial Cancer Cells.
Ratovitski EA
Curr Genomics; 2013 Nov; 14(7):441-52. PubMed ID: 24396276
[TBL] [Abstract][Full Text] [Related]
2. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
Ratovitski EA
FEBS Lett; 2013 Aug; 587(16):2536-41. PubMed ID: 23831023
[TBL] [Abstract][Full Text] [Related]
3. Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.
Ratovitski EA
Cell Cycle; 2014; 13(5):749-61. PubMed ID: 24394434
[TBL] [Abstract][Full Text] [Related]
4. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
5. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
6. TP63 gene in stress response and carcinogenesis: a broader role than expected.
Petitjean A; Hainaut P; Caron de Fromentel C
Bull Cancer; 2006 Dec; 93(12):E126-35. PubMed ID: 17182369
[TBL] [Abstract][Full Text] [Related]
7. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
8. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
10. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
11. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
[TBL] [Abstract][Full Text] [Related]
12. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
13. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
14. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
15. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
17. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
18. microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.
Fujii T; Shimada K; Tatsumi Y; Hatakeyama K; Obayashi C; Fujimoto K; Konishi N
BMC Cancer; 2015 Oct; 15():818. PubMed ID: 26514209
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome.
Speciale A; Monti P; Fronza G; Izzotti A; Menichini P
Microrna; 2020; 9(5):322-335. PubMed ID: 33297928
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.
Guo F; Parker Kerrigan BC; Yang D; Hu L; Shmulevich I; Sood AK; Xue F; Zhang W
J Hematol Oncol; 2014 Mar; 7():19. PubMed ID: 24598126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
